International Journal of Hematology and Oncology
2023 , Vol 33 , Num 2
Ibrahim Ethem PINAR, Vildan OZKOCAMAN, Tuba ERSAL, Elif YIGIT AYHAN, Vildan GURSOY, Cumali YALCIN, Bedrettin ORHAN, Omer CANDAR, Fahir OZKALEMKAS
Comparison of International Prognostic Indices and Validation Study for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era. UHOD , 2023 , 33 , 057-065
Seyhan TURK, Ayriana Safari BAESMAT, Aysegul YILMAZ, Umit Yavuz MALKAN, Can TURK, Ibrahim Celalettin HAZNEDAROGLU, Gulberk UCAR Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s Dysfunction. UHOD , 2023 , 33 , 066-074
Utku ILTAR, Ece VURAL, Fadime Nurcan ALHAN, Sertac VURGUN, Unal ATAS, Orhan Kemal YUCEL, Ozan Salim, Turgay ULAS, Mert COSKUN, Asli TOYLU, Sibel Berker KARAUZUM, Levent UNDAR Real-Life Experience of Dose-Adjusted Venetoclax in Acute Myeloid Leukemia Patients Concomitantly Using Posaconazole for Antifungal Prophylaxis: A Single-Center Experience. UHOD , 2023 , 33 , 075-082
Ayse ARSLAN KAPUCI, Pinar TIGLIOGLU, Lutfiye Tuba HANCI, Hanife SAAT, Umit Yavuz MALKAN The Impact of JAK2 Mutation on Thrombosis in Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms. UHOD , 2023 , 33 , 083-091
Melda SARIMAN, Burcu SALMAN YAYLAZ, Aysegul YABACI TAK, Mesut AYER, Sema SIRMA EKMEKCI, Ilknur SUER, Kivanc CEFLE, Sukru PALANDUZ, Sukru OZTURK, Meliha NALCACI, Neslihan ABACI Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. UHOD , 2023 , 33 , 092-102
Bahiddin YILMAZ, Demet GUR VURAL, Demet ISIK BAYRAKTAR, Ozden DEMIR, Murat ALAN, Mesut AYDIN, Asuman BIRINCI Immunogenicity and Safety of CoronaVac Vaccine in Elderly Cancer Patients Receiving Cytotoxic Chemotherapy. UHOD , 2023 , 33 , 103-111
Alper COSKUN, Utku CAN, Cengiz CANAKCI C-reactive Protein /Albumin Ratio Relationship in Testicular Cancer and Comparison with Non-Cancerous Patients: Another New and Meaningful Parameter. UHOD , 2023 , 33 , 112-117
Ibrahim GULLU, Ahmet Arda UNAL Neutropenia and Low Infection Rates Dilemma of the CDK Inhibitors: A New Theory. UHOD , 2023 , 33 , 118-119
Seyhan TURK, Ayriana Safari BAESMAT, Aysegul YILMAZ, Umit Yavuz MALKAN, Can TURK, Ibrahim Celalettin HAZNEDAROGLU, Gulberk UCAR Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s Dysfunction. UHOD , 2023 , 33 , 066-074
Utku ILTAR, Ece VURAL, Fadime Nurcan ALHAN, Sertac VURGUN, Unal ATAS, Orhan Kemal YUCEL, Ozan Salim, Turgay ULAS, Mert COSKUN, Asli TOYLU, Sibel Berker KARAUZUM, Levent UNDAR Real-Life Experience of Dose-Adjusted Venetoclax in Acute Myeloid Leukemia Patients Concomitantly Using Posaconazole for Antifungal Prophylaxis: A Single-Center Experience. UHOD , 2023 , 33 , 075-082
Ayse ARSLAN KAPUCI, Pinar TIGLIOGLU, Lutfiye Tuba HANCI, Hanife SAAT, Umit Yavuz MALKAN The Impact of JAK2 Mutation on Thrombosis in Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms. UHOD , 2023 , 33 , 083-091
Melda SARIMAN, Burcu SALMAN YAYLAZ, Aysegul YABACI TAK, Mesut AYER, Sema SIRMA EKMEKCI, Ilknur SUER, Kivanc CEFLE, Sukru PALANDUZ, Sukru OZTURK, Meliha NALCACI, Neslihan ABACI Evaluation of TMED9, DNAJC1, LMAN2, COPE and KDELR1 Biomarkers in Patients with Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. UHOD , 2023 , 33 , 092-102
Bahiddin YILMAZ, Demet GUR VURAL, Demet ISIK BAYRAKTAR, Ozden DEMIR, Murat ALAN, Mesut AYDIN, Asuman BIRINCI Immunogenicity and Safety of CoronaVac Vaccine in Elderly Cancer Patients Receiving Cytotoxic Chemotherapy. UHOD , 2023 , 33 , 103-111
Alper COSKUN, Utku CAN, Cengiz CANAKCI C-reactive Protein /Albumin Ratio Relationship in Testicular Cancer and Comparison with Non-Cancerous Patients: Another New and Meaningful Parameter. UHOD , 2023 , 33 , 112-117
Ibrahim GULLU, Ahmet Arda UNAL Neutropenia and Low Infection Rates Dilemma of the CDK Inhibitors: A New Theory. UHOD , 2023 , 33 , 118-119